Literature DB >> 6619284

Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection.

P D Swenson, M R Escobar, R L Carithers, T J Sobieski.   

Abstract

We studied a patient who developed acute hepatitis B virus (HBV) infection despite the presence of preexisting antibody to the surface antigen of HBV (anti-HBs). Anti-HBs has been reported to consist primarily of antibody against the common a determinant of HBV. Antibody directed against this major determinant appears to confer protection against HBV, regardless of the subtype. Our patient was shown to have had preexisting anti-HBs of anti-d but not anti-a specificity. She subsequently developed non-A, non-B viral hepatitis followed by an episode of acute hepatitis B after exposure to HBV of the ayw subtype.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619284      PMCID: PMC270796          DOI: 10.1128/jcm.18.2.305-309.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg.

Authors:  D E Koziol; H J Alter; J P Kirchner; P V Holland
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

2.  Detection of additional antigenic determinants of hepatitis B antigen.

Authors:  W H Bancroft; F K Mundon; P K Russell
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

3.  The heterogeneity of Australia antigen.

Authors:  G L Le Bouvier
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

4.  Passive hemagglutination assay for antibody to subtypes of hepatitis B antigen.

Authors:  J W Gold; H J Alter; P V Holland; J L Gerin; R H Purcell
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

5.  Hepatitis B antigen: regional variation in incidence and subtype ratio in the American Red Cross donor population.

Authors:  R Y Dodd; P V Holland; L Y Ni; H M Smith; T J Greenwalt
Journal:  Am J Epidemiol       Date:  1973-02       Impact factor: 4.897

6.  Subtypes of Australia antigen among patients and healthy carriers in Copenhagen. A relation between the subtypes and the degree of liver damage in acute viral hepatitis.

Authors:  J O Nielsen; G L Le Bouvier
Journal:  N Engl J Med       Date:  1973-06-14       Impact factor: 91.245

7.  Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay.

Authors:  J H Hoofnagle; R J Gerety; L A Smallwood; L F Barker
Journal:  Gastroenterology       Date:  1977-02       Impact factor: 22.682

8.  Further data on HBs antigen subtypes - geographical distribution.

Authors:  A M Couroucé-Pauty; J P Soulier
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

9.  Effects of cyclophosphamide on hepatitis B virus infection and challenge in chimpanzees.

Authors:  J A Markenson; R J Gerety; J H Hoofnagle; L F Barker
Journal:  J Infect Dis       Date:  1975-02       Impact factor: 5.226

10.  Changing patterns in the distribution of hepatitis B subtypes.

Authors:  I D Gust; M Dimitrakakis; C R Lucas
Journal:  Vox Sang       Date:  1980-02       Impact factor: 2.144

View more
  4 in total

1.  Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.

Authors:  M W Steward; B M Sisley; C Stanley; S E Brown; C R Howard
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

Review 2.  Exposure to hepatitis B: review of current concepts.

Authors:  F H Zimmerman; G P Wormser
Journal:  Bull N Y Acad Med       Date:  1989-09

3.  Clinical significance of concurrent hepatitis B surface antigen and antibody positivity.

Authors:  T K Tsang; A T Blei; D J O'Reilly; R Decker
Journal:  Dig Dis Sci       Date:  1986-06       Impact factor: 3.199

4.  Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.

Authors:  Hai-Ying Lu; Zheng Zeng; Xiao-Yuan Xu; Nai-Lin Zhang; Min Yu; Wei-Bo Gong
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.